Neuroectodermal Tumors

Search with Google Search with Bing
Information
Disease name
Neuroectodermal Tumors
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03911388 Active, not recruiting Phase 1 HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors September 12, 2019 September 1, 2026
NCT05592743 Available Vorasidenib Expanded Access Program
NCT02372006 Completed Phase 1/Phase 2 Trial of Afatinib in Pediatric Tumours April 29, 2015 August 5, 2020
NCT02798406 Completed Phase 2 Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects October 6, 2016 June 30, 2021
NCT03037385 Completed Phase 1/Phase 2 Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors March 17, 2017 March 21, 2024
NCT05850377 Not yet recruiting 5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas June 1, 2023 May 31, 2026
NCT03561259 Recruiting Phase 2 A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects October 21, 2019 April 2025
NCT04541082 Recruiting Phase 1 Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms October 26, 2020 February 2025
NCT04949282 Recruiting Spanish Series of Patients Treated With the Radionuclide Lutetium177 May 10, 2021 December 31, 2035
NCT04388033 Unknown status Phase 1/Phase 2 Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. December 2020 December 2023
NCT01579253 Unknown status Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients April 2012
NCT00686387 Unknown status Establishment of a Brain and Spinal Tumor Tissue Bank May 2008 May 2013
MeSH unique ID (MeSH (Medical Subject Headings))
D017599